Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Mice with autoimmune hair loss showed signs of heart problems.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Wigs significantly improve the well-being of people with severe hair loss.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Allergies and atopic conditions may increase the risk of developing alopecia areata.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Certain gene variations increase the risk of alopecia areata in Koreans.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Climate factors like UV index and rain can affect alopecia areata flares in children, especially those with allergies.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

The criteria help doctors diagnose and treat alopecia areata more effectively.